Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide works best when the medicine is matched with consistent habits around food, activity, sleep and injection timing. Clinical trial data from the STEP 1 programme showed average weight loss of around 15% over 68 weeks — but that figure came from participants following structured lifestyle support alongside the medicine, not from the injection alone. Semaglutide is a prescription-only medicine; a clinician assesses whether it is appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, randomised over 1,900 adults with obesity and gave every participant (semaglutide or placebo) structured counselling on diet and physical activity. The ~15% average weight reduction seen at 68 weeks on 2.4 mg semaglutide was achieved in that context. Participants who engaged most consistently with the behavioural programme tended to sit at the higher end of results. This matters practically: the medicine suppresses appetite and slows gastric emptying, but it does not choose what you eat, how much protein you prioritise, or how often you move. Those decisions still belong to you.
The NHS tirzepatide and semaglutide medicines guidance both emphasise that these treatments are intended alongside a reduced-calorie diet and increased physical activity, not instead of them. If you want to understand the full mechanism behind that (why appetite reduction alone is not the whole story) our page on how semaglutide works covers the GLP-1 pathway in more depth.
One practical implication: the period just after a dose increase is when nausea is most likely. Eating smaller portions, choosing low-fat options and avoiding very rich or spicy meals in the days after your injection can reduce side effects and help you stay consistent. Pushing through discomfort by eating less thoughtfully tends to do the opposite.
A common pattern on semaglutide is that overall food intake falls sharply, which is the point, but if the food that remains is low in protein and fibre, muscle loss and energy dips can follow. The British Dietetic Association's food-fact guidance and clinical practice both point to protein adequacy as a priority during active weight loss: roughly 1.2–1.6 g per kilogram of body weight per day is a commonly cited range in the literature, though your prescriber or a dietitian can advise on a figure that suits your situation.
Fibre matters for two reasons on this treatment. First, semaglutide slows gastric emptying, which means constipation is a genuine side effect for some people, adequate fibre and hydration help. Second, fibre-rich foods tend to sustain the fullness that semaglutide is already promoting, meaning smaller meals still feel satisfying. Vegetables, legumes, whole grains and fruit cover both bases without adding much caloric density. If nausea is a problem, our guide on managing day-to-day wellbeing on Wegovy has specific suggestions drawn from clinical guidance.
Alcohol is worth flagging separately. It adds calories without nutritional value, can disrupt sleep and affects glucose regulation, all of which work against what semaglutide is trying to do. Cutting back is not a requirement, but the people who get most from the medicine tend to treat it as part of a wider shift, not a single fix.
Semaglutide's half-life is approximately one week, which is why it is taken weekly rather than daily. That pharmacokinetic profile means a late injection does not cause the same peaks and troughs you might see with a shorter-acting drug, but consistency still matters. Injecting on the same day each week keeps plasma concentrations stable, which is the goal. Missing a dose by a day occasionally is recoverable; frequent gaps are not.
Site rotation (abdomen, thigh, upper arm) is worth taking seriously. Injecting repeatedly into the same small patch of skin can cause lipohypertrophy (a thickening of fatty tissue), which impairs absorption. Rotating between and within sites keeps absorption reliable. Some people find that choosing a consistent time of day alongside their chosen day helps turn the injection into a habit; others find that because the weekly window is wide, timing it around a fixed weekly routine (Sunday evening once the weekend is settled, for instance) works better than a rigid hour.
There is reasonable interest in whether morning or evening injections make a difference. The clinical consensus is that it matters far less than consistency, but if you want to look at the specific question, our page on Wegovy injection timing covers what the evidence and the SmPC say. For a broader look at how long the medicine typically takes to produce noticeable effects, this page on semaglutide's timeline is worth reading alongside this one.
Semaglutide acts on GLP-1 receptors involved in appetite regulation, but appetite is not controlled by one pathway. Poor sleep raises ghrelin (a hunger hormone) and suppresses leptin (a satiety signal). Chronic psychological stress elevates cortisol, which drives cravings for high-calorie foods and promotes fat deposition, particularly around the abdomen. Neither of these is neutralised by the medicine alone.
This is not to say the medicine stops working if your sleep is imperfect, it clearly still suppresses appetite substantially. But the gap between someone's average result and their best plausible result on semaglutide is often found here. Addressing sleep and stress is therefore not soft wellness advice; it is part of making the pharmacology do its job. The NHS Better Health weight-loss resource includes practical guidance on behavioural factors alongside dietary ones, which complements what the medicine is doing biologically.
One question our prescribers hear regularly: does it matter which version of semaglutide you take? The injection (Wegovy) and the newer oral tablet reach the same receptor but via different routes, with different pharmacokinetic profiles. If that comparison is relevant to your decision, this page weighing up the options lays it out clearly. Semaglutide is a prescription-only medicine; everything discussed here is in addition to (never a replacement for) the clinical assessment and ongoing review that legitimate prescribing requires. If you are considering treatment through a regulated UK pharmacy, checking your eligibility is the right first step. Our prescribers are also happy to answer questions about your specific circumstances via the contact page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.